Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07168993
NA

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Sponsor: bioAffinity Technologies Inc.

View on ClinicalTrials.gov

Summary

Evaluate FlowPath Lung Diagnostic Test of Sputum Samples to Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, \>6 to \<30 mm in Diameter, Determined by LDCT.

Official title: Detection of Early-Stage Lung Cancer in Sputum Using Flow Cytometry and an Automated Analysis Pipeline

Key Details

Gender

All

Age Range

50 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

2063

Start Date

2026-02-25

Completion Date

2029-07-01

Last Updated

2026-03-18

Healthy Volunteers

No

Interventions

OTHER

Standard medical treatment

Standard of care follow up per institution

OTHER

Standard medical treatment

SOC per institution

Locations (3)

Clinical Research Associates of Central Pennsylvania

DuBois, Pennsylvania, United States

Audie Murphy VA Medical Center

San Antonio, Texas, United States

Brooke Army Medical Center

San Antonio, Texas, United States